This company is a manufacturer and exporter of various healthcare products, including pharmaceuticals, nutraceuticals, surgical items, and cosmetics. They specialize in a wide range of dosage forms for their pharmaceutical products, such as tablets, capsules (hard and softgel), oral powders, and liquids. The company focuses on providing affordable generic medications across key regions like the EU and North America. Their commitment to quality is reflected in their state-of-the-art manufacturing facilities that adhere to global standards and GMP certifications. While specific therapy areas and patents aren't mentioned, they highlight a client-centric approach and timely delivery of regulatory documents.
Ursodeoxycholic acid is a bile acid used to treat gallstones as well as to treat and prevent the progression of cystic fibrosis-related liver disorders. Suppliers of ursodeoxycholic acid market it in the form of 150mg, 250mg and 500mg oral tablets and capsules.
The market for ursodeoxycholic acid is relatively competitive, populated with numerous manufacturing companies and suppliers. The largest manufacturers of ursodeoxycholic acid market globally are companies Mitsubishi Tanabe Pharma, Daewoong Chemical, and PharmaZell, Glenmark Pharmaceuticals, Dipharma Francis, Errengierre, and Grindeks.
Ursodeoxycholic acid suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified ursodeoxycholic acid manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 50 (250mg) tablets of ursodeoxycholic acid fall into an approximate range of 12,00 EUR to 15,00 EUR, whereas the equivalent amount of 500mg tablets cost from 25,00 EUR to 30,00 EUR.